Overview

HAIP Combined With Fuquinitinib as Late-line Treatment in Patients With CRLMA Phase 2 Single-Arm Clinical Trial

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-12-30
Target enrollment:
Participant gender:
Summary
This study was a phase 2, single-arm, single-center clinical trial in which previously treated patients with unresectable colorectal cancer liver metastases.
Phase:
PHASE2
Details
Lead Sponsor:
Meng Qiu